Important notifications related to the company are listed here. Notifications may come from the SEC, exchanges such as the NYSE or NASDAQ or Watchdog Research. Examples of notifications include announcements of bankruptcy proceedings, company name changes, and noncompliance with SEC regulations or exchange rules.
There are no notifications for Genmab at least since 2017.

Peer Group

Peer groups are used by companies to benchmark executive compensation and performance. Each company identifies its own peer group. Peer groups vary from company to company.

Peer Group

Company Ticker Market Cap
Genmab A/S GMAB $28.1b
Viatris Inc * VTRS $16.6b
Zai Lab Ltd. * ZLAB $12.1b
Dr Reddys Laboratories Ltd. * RDY $11.1b
Grifols S.A. * GRFS $9.94b
Teva Pharmaceutical Industries Ltd. * TEVA $9.87b
Mirati Therapeutics, Inc. * MRTX $8.73b
Ascendis Pharma A/S * ASND $8.58b
AbCellera Biologics Inc. * ABCL $5.52b
Acadia Pharmaceuticals Inc. * ACAD $2.83b

Companies Who Named Genmab as a Peer

Genmab is not named as a peer by any company.
* Suggested by Watchdog.


Peer Flag Comparison

The return to a company’s stock is not the only measure of executive performance. Ethics matter, and growth can quickly reverse and gains evaporate if a company’s accounting and financial reporting processes are not fundamentally sound and trustworthy. How does Genmab's accounting quality compare to its peer group?

Full Watchdog Reports are written for serious investors and professionals and are available through a paid subscription. Get the full details for each company's flags including detailed explanations and links to that company's original public disclosures for yellow or red flags (via SEC, regulatory or legal filings). These underlying documents give you a more complete understanding for each flag event.

View pricing & subscribe

If you would like to see what a Full Company Report looks like, we allow free unrestricted access for General Electric Co [GE]